Trials / Completed
CompletedNCT06656026
Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A
A Open-label Phase 2 Study of ZSP1273 in Otherwise Healthy Children 2-17 Years Old With Influenza A
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 2 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in China. The aim of the trial is to investigate safety,pharmacokinetics and pharmacodynamics of ZSP1273 granules
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZSP1273 granules | Oral |
Timeline
- Start date
- 2024-11-30
- Primary completion
- 2025-06-30
- Completion
- 2025-07-31
- First posted
- 2024-10-24
- Last updated
- 2025-11-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06656026. Inclusion in this directory is not an endorsement.